Seres Therapeutics, Inc. is a business entity registered at Global Legal Entity Identifier Foundation (GLEIF), with entity identifier is 549300GMXBE5NUWISF13. The registration start date is May 28, 2015.
Legal Entity Identifier (LEI) | 549300GMXBE5NUWISF13 |
Legal Name |
Seres Therapeutics, Inc. |
Legal Address |
C/O The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington Delaware 19801 United States |
Headquarters Address |
215 1st Street Cambridge Massachusetts 02142 United States |
Legal Jurisdiction | United States - Delaware |
Legal Form | INCORPORATED |
Entity Status | ACTIVE |
Registration Authority ID | RA999999 |
Managing Local Operating Unit (LOU) |
EVK05KS7XY1DEII3R011 Business Entity Data B.V. (GMEI Utility a service of BED B.V.) |
Initial Registration Date | 2015-05-28T01:45:00.000Z |
Last Update Date | 2020-07-20T14:15:00.000Z |
Registration Status | LAPSED |
Next Renewal Date | 2016-05-25T11:45:00.000Z |
Validation Sources | ENTITY_SUPPLIED_ONLY |
Validation Authority ID | RA999999 |
Headquarters Address |
215 1st Street |
City | Cambridge |
Region | Massachusetts (US-MA) |
Postal Code | 02142 |
Country | United States (US) |
Entity Name | Headquarters Address |
---|---|
Sage Therapeutics, Inc. | 215 1st Street , Cambridge |
Sesen Bio, Inc. | 215 1st Street Suite 400, Cambridge |
Please provide details on Seres Therapeutics, Inc. by submitting the form below, or post on facebook comments.
Note that the information provided will be posted publicly on this web page. Please do not leave private contact information here. If you would like to contact us, please use this form.
Register Name | Global Legal Entity Identifier Foundation (GLEIF) |
Jurisdiction | Global LEI |
Website | www.gleif.org |
Entity Count | 586000 |